S. 2623 · 114th Congress

Protecting Americans from Drug Marketing Act

Stage
In committee
Sponsor
Al Franken
Introduced
2016-03-03
Latest action
2016-03-03 · Introduced in Senate

Summary

Protecting Americans from Drug Marketing Act

This bill amends the Internal Revenue Code to deny a tax deduction for the cost of direct-to-consumer advertising of prescription drugs. The bill defines "direct-to-consumer advertising" as any dissemination by or on behalf of a sponsor of a prescription drug product of a prescription drug advertisement that is primarily targeted to the general public through: (1) publication in journals, magazines, other periodicals, and newspapers; (2) broadcasting through media such as radio, television, and telephone communication systems; and (3) dissemination on the Internet (including social media).